Lertxundi, Nerea http://orcid.org/0000-0002-7344-4433
Molinuevo, Amaia
Valvi, Dania
Gorostiaga, Arantxa
Balluerka, Nekane
Shivappa, Nitin
Hebert, James
Navarrete-Muñoz, Eva María
Vioque, Jesus
Tardón, Adonina
Vrijheid, Martine
Roumeliotaki, Theano
Koutra, Katerina
Chatzi, Leda
Ibarluzea, Jesus
Funding for this research was provided by:
Instituto de Salud Carlos III (G03/176, CB06/02/0041, FIS-PI041436, FIS- PI081151, FIS-PI042018, FISPI09/02311, FIS-PI06/0867, FIS-PS09/00090, FIS-FEDER PI11/1007 FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931 , 05/1079, 05/1052, 06/1213, 07/0314, and 09/02647)
Departament de Salut, Generalitat de Catalunya (CIRIT 1999SGR 00241,)
National Institute of environmental health sciences (R21 ES029328, R21 ES028903)
Article History
Received: 4 May 2020
Accepted: 9 December 2020
First Online: 4 January 2021
Compliance with ethical standards
:
: Dr. James R. Hébert owns controlling interest in Connecting Health Innovations LLC (CHI), a company planning to license the right to his invention of the dietary inflammatory index (DII) from the University of South Carolina to develop computer and smart phone applications for patient counselling and dietary intervention in clinical settings. Dr. Nitin Shivappa is an employee of CHI. All other authors declare that they have no conflict of interest.
: The INMA Project was approved by the Hospital Ethics Committees in the participating regions and hospitals. The RHEA study was approved by the ethical committee of the University Hospital in Heraklion, Crete (Greece).